Bioremedy Pharma at CPHI Europe 2025

Bioremedy Pharma attended CPHI Europe 2025, advancing inbound licensing partnerships and expanding access to innovative healthcare products across Africa and the Middle East.

Bioremedy Pharma at CPHI Europe 2025

Global Industry Presence

Our team represented Bioremedy Pharma at CPHI Europe 2025 in Frankfurt, one of the world's largest pharmaceutical trade exhibitions, bringing together professionals from across the entire pharmaceutical value chain.

We engaged with global innovators seeking a trusted partner to register, market, and distribute their products across the Africa and Middle East (AFME) region, holding discussions across our therapeutic areas including metabolic, neuropsychiatry, women's health, dermatology, and wound care.

Building Strategic Partnerships

During the event, our business development team held productive meetings with pharmaceutical, medical device, and consumer healthcare companies looking for a well connected local partner to enter and grow in Saudi Arabia and the wider AFME region. These discussions align with Bioremedy Pharma's model of inbound licensing innovative healthcare products from global innovators and serving as their partner of choice for registration, market access, and distribution.

CPHI Europe continues to be a cornerstone event for Bioremedy Pharma's international engagement strategy as we expand our network of global partnerships.